Frank J Amodio, MD in Evansville, IN - Allergy & Immunology

Frank J Amodio, MD is a Allergy & Immunology physician based in Evansville, Indiana. Frank J Amodio is licensed to practice in Indiana (license number 01030042A) and his current practice location is 3700 Bellemeade Avenue, Suite 201, Evansville, Indiana. He can be reached at his office (for appointments etc.) via phone at (812) 479-3153.

NPI number for Frank J Amodio is 1538273271 and his current mailing address is 3700 Bellemeade Avenue, Suite 201, Evansville, Indiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1538273271.

Contact Information

	Frank J Amodio, MD
	3700 Bellemeade Avenue, Suite 201, Evansville, IN 47714
	(812) 479-3153
	(812) 473-8166

Physician's Profile

Full Name	Frank J Amodio
Gender	Male
Speciality	Allergy & Immunology
Location	3700 Bellemeade Avenue, Evansville, Indiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1538273271
Provider Enumeration Date: 08/19/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Frank J Amodio such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538273271	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	01030042A (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Frank J Amodio is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Frank J Amodio, MD 3700 Bellemeade Avenue, Suite 201, Evansville, IN 47714 Ph: (812) 479-3153	Frank J Amodio, MD 3700 Bellemeade Avenue, Suite 201, Evansville, IN 47714 Ph: (812) 479-3153

News Archive

Inhibiting necroptosis could be a novel approach for treating COPD

Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease, an inflammatory lung condition, also known as emphysema, that makes it difficult to breathe.

Global partnership accelerates progress in maternal, child health

In a post in the State Department's "DipNote" blog, Scott Radloff, director of the Office of Population and Reproductive Health at USAID, examines how, for the past year, the Alliance for Reproductive, Maternal, and Newborn Health, a partnership between USAID, the U.K. Department for International Development, the Australian Agency for International Development and the Bill & Melinda Gates Foundation launched at last year's U.N. General Assembly Summit on the Millennium Development Goals, has "accelerated progress in improving maternal and child health" worldwide.

Scientists use metabolomics to discover DMS linked with neuropathic pain

Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system.

OncoGenex terminates agreement with Teva, regains rights to custirsen

OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.

COVID-19 vaccine uptake low among pregnant women in U.S., study finds

Despite the availability of vaccines, the U.S. CDC reports that there has been a lack of pregnant women who are getting vaccinated against SARS-CoV-2.

Allergy & Immunology Doctors in Evansville, IN

Mythili Gurram, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 827 S Green River Rd, Evansville, IN 47715 Phone: 812-473-7225
Jason F White, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6221 Physicians Ct, Suite 1, Evansville, IN 47715 Phone: 812-479-3153 Fax: 812-473-8166
Majed A Koleilat, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 421 Chestnut St, Evansville, IN 47713 Phone: 812-426-9459 Fax: 812-858-4546
Anne P Mclaughlin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 421 Chestnut St, Evansville, IN 47713 Phone: 812-426-9459 Fax: 812-858-4546

Frank J Amodio, MD - Allergy & Immunology in Evansville, IN